Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Designing the First Trials for Parkinson's Prevention.
Journal: Journal of Parkinson's disease
Published: September 20, 2024
Short-term lipopolysaccharide treatment leads to astrocyte activation in LRRK2 G2019S knock-in mice without loss of dopaminergic neurons.
Journal: Research square
Published: April 02, 2024
Perspectives of People At-Risk on Parkinson's Prevention Research.
Journal: Journal of Parkinson's disease
Published: March 15, 2024
Short-term lipopolysaccharide treatment leads to astrocyte activation in LRRK2 G2019S knock-in mice without loss of dopaminergic neurons.
Journal: BMC neuroscience
Published: March 11, 2024
Toward More Accessible Fully Automated 3D Volumetric MRI Decision Trees for the Differential Diagnosis of Multiple System Atrophy, Related Disorders, and Age-Matched Healthy Subjects.
Journal: Cerebellum (London, England)
Published: August 27, 2022
Planning for Prevention of Parkinson Disease: Now Is the Time.
Journal: Neurology
Published: October 29, 2021
What to Test in Parkinson Disease Prevention Trials? Repurposed, Low-Risk, and Gene-Targeted Drugs.
Journal: Neurology
Published: October 15, 2021
Path to Parkinson Disease Prevention: Conclusion and Outlook.
Journal: Neurology
Published: October 15, 2021
If LRRK2 Set the Fire, Can Nonsteroidal Anti-inflammatory Drugs Wet the Flames?
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: July 10, 2020
Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers: A metabolomic study.
Journal: Neurology
Published: May 30, 2020
Chasing Protection in Parkinson's Disease: Does Exercise Reduce Risk and Progression?
Journal: Frontiers in aging neuroscience
Published: January 31, 2020
Last Updated: 09/26/2026